Lysophosphatidic acid (LPA) utilizes a G-protein-coupled receptor to activate the small GTP-binding protein Rho and to induce rapid remodeling of the actin cytoskeleton. We studied the signal transduction from LPA receptors to Rho activation. Analysis of the G-protein-coupling pattern of LPA receptors by labeling activated G-proteins with [␣-32 P]GTP azidoanilide revealed interaction with proteins of the G q , G i , and G 12 subfamilies. We could show that in COS-7 cells, expression of GTPase-deficient mutants of G␣ 12 and G␣ 13 triggered Rho activation as measured by increased Rho-GTP levels. In Swiss 3T3 cells, incubation with LPA or microinjection of constitutively active mutants of G␣ 12 and G␣ 13 induced formation of actin stress fibers and assembly of focal adhesions in a Rho-dependent manner. Interestingly, the LPA-dependent cytoskeletal reorganization was suppressed by microinjected antibodies directed against G␣ 13 , whereas G␣ 12 -specific antibodies showed no inhibition. The tyrosine kinase inhibitor tyrphostin A 25 and the epidermal growth factor (EGF) receptorspecific tyrphostin AG 1478 completely blocked actin stress fiber formation caused by LPA or activated G␣ 13 but not the effects of activated G␣ 12 . Also, expression of the dominant negative EGF receptor mutant EGFR-CD533 markedly prevented the LPA-and G␣ 13 -induced actin polymerization. Coexpression of EGFR-CD533 and activated G␣ 13 in COS-7 cells resulted in decreased Rho-GTP levels compared with expression of activated G␣ 13 alone. These data indicate that in Swiss 3T3 cells, G 13 but not G 12 is involved in the LPA-induced activation of Rho. Moreover, our results suggest an involvement of the EGF receptor in this pathway.
Upon stimulation, a number of heterotrimeric G-proteincoupled receptors initiate cellular responses involving small GTP-binding proteins. For instance, the water-soluble phospholipid lysophosphatidic acid (LPA) 1 binds to a G-proteincoupled heptahelical receptor (1, 2) and stimulates the activation of Ras and Rho proteins via different pathways (3, 4) . In fibroblasts, LPA lowers cAMP levels in a pertussis toxin (PTX)-sensitive manner, suggesting the coupling of the LPA receptor to G-proteins of the G i subfamily (5) . LPA-induced activation of the Ras/Raf/mitogen-activated protein kinase cascade also occurs in a PTX-sensitive fashion (3, 6) , and G␤␥ dimers of heterotrimeric G-proteins are thought to transduce this effect via intermediary protein-tyrosine kinases (7, 8) . In contrast, in a large variety of cells, the stimulation of phospholipase C induced by LPA was shown to be PTX-insensitive (9) , suggesting a coupling of the LPA receptor to members of the G q subfamily. In addition to these pathways, LPA induces the Rho-dependent formation of focal adhesions and actin stress fibers in quiescent Swiss 3T3 fibroblasts (4, 10) . A tyrosine kinase has been implicated in the LPA-induced Rho stimulation, since the tyrosine kinase inhibitor tyrphostin A 25 blocks the effects of LPA but not of microinjected Rho on actin polymerization (11) . However, the G-proteins coupling the LPA receptor to Rho activation have not been specified. LPA-induced cytoskeletal reorganizations are PTX-insensitive and therefore presumably not transmitted via G i subfamily members (12) . G q proteins are apparently not involved in this pathway, because neither the activation of protein kinase C nor mobilization of intracellular calcium or expression of a GTPase-deficient mutant of G␣ q induces the formation of actin stress fibers or focal adhesions (12) (13) (14) . Interestingly, microinjection of constitutively active mutants of G␣ 12 and G␣ 13 into Swiss 3T3 cells triggers actin polymerization in a Rho-dependent manner (13) .
In the present study, we determined the G-protein coupling pattern of the LPA receptor in membrane preparations and characterized the pathway leading from LPA receptor activation to stress fiber formation in intact cells. We report direct coupling of the LPA receptor to proteins of the G 12 , G q , and G i subfamilies. Furthermore, our data suggest that in intact cells G 13 but not G 12 mediates LPA-induced Rho activation involving the epidermal growth factor (EGF) receptor tyrosine kinase activity.
EXPERIMENTAL PROCEDURES
Cell Culture-Swiss 3T3 cells, kindly provided by Dr. Alan Hall (London), and COS-7 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum. To obtain quiescent and serum-starved Swiss 3T3 cells, cultures were rinsed three times in serum-free DMEM and incubated in DMEM supplemented with 25% Ham's F-12, 0.2% NaHCO 3 , 10 mM Na-Hepes, and 0.1% fetal bovine serum (modified DMEM) for 24 h followed by an incubation in modified DMEM without fetal bovine serum for 18 h.
Membrane Preparations-Membranes were prepared from subconfluent Swiss 3T3 cells. Cells were rinsed and scraped in a buffer containing 20 mM Tris/HCl, pH 8, 1 mM EDTA, 140 mM NaCl, 20 mM ␤-mercaptoethanol, and 10 mM phenylmethylsulfonylfluoride. The pelleted cells were resuspended in the buffer described above devoid of NaCl but containing 20 g/ml leupeptin. Cells were disrupted by forcing the suspension 10 times through a 26-gauge needle. Undisrupted cells were pelleted (750 ϫ g, 2 min), and the supernatant was centrifuged at 50,000 ϫ g for 30 min at 4°C. Membranes were resuspended and stored at Ϫ70°C until use. Protein concentrations were determined according to Lowry et al. (15) .
SDS-PAGE and
Immunoblotting-For immunological detection of G-proteins, SDS-PAGE using 10% (w/v) polyacrylamide separating gels was employed. Proteins were transferred to nitrocellulose as described (16) . The subtype specific antisera AS 232 and AS 233 (anti-␣ 12 ); AS 343, AS 342, and AS 272 (anti-␣ 13 ); AS 369 (anti-␣ q/11 ), and AS 266 (anti-␣ i ) were characterized previously (17) . Antisera against G␣ 12 were incubated with the peptides (10 g/ml) used for their generation, as published elsewhere (17, 18) . Detection of filter-bound proteins was carried out using the enhanced chemiluminescence (ECL) Western blotting system purchased from Amersham (19) .
Photolabeling of G␣ Subunits-Synthesis of [␣-32 P]GTP azidoanilide from [␣- 32 P]GTP (NEN Life Science Products) was performed according to published protocols (20) . For photolabeling of G␣ subunits, sedimented Swiss 3T3 membranes (200 g of protein/tube) were preincubated in the absence or presence of 10 M LPA at 30°C, followed by the addition of [␣-
32 P]GTP azidoanilide (3 Ci/tube; specific activity 3,000 Ci/mmol) at 30°C for different times: 3 min for G␣ i , 10 min for G␣ q/11 , and 30 min for G␣ 12 and G␣ 13 (18) . Samples were irradiated for 15 s at 4°C with a 254-nm UV lamp. Photolabeled membranes were pelleted and solubilized in 40 l of 4% SDS (w/v) at room temperature, followed by the addition of precipitating buffer (280 l) containing 10 mM Tris/ HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% deoxycholate (w/v), 1% Nonidet P-40 (w/v), 1 mM dithiothreitol, 0.2 M phenylmethylsulfonylfluoride, and 10 g/ml aprotinin. Samples were centrifuged (13,000 ϫ g) for 5 min at 4°C to remove insoluble material. The antisera (20 l) AS 369 for G␣ q/11 , AS 233 for G␣ 12 , AS 343 for G␣ 13 , and AS 266 for G␣ i were added to the supernatants followed by constant rotation of the samples for 2 h at 4°C. Protein A-Sepharose beads (7 g) were added, and samples were incubated at 4°C overnight. The immunoprecipitates were washed three times, boiled in SDS-sample buffer, and subjected to SDS-PAGE. Gels were subsequently dried and analyzed using autoradiography.
Transient Transfection of COS-7 Cells and Rho Activation AssayFor transfection experiments, 1.2 ϫ 10 5 COS-7 cells were plated in 10-cm diameter cell culture dishes, grown overnight, and subsequently serum-starved for 18 h. Cells were then washed with phosphate-buffered saline, and 12 g of DNA mixed with 60 l of LipofectAMINE (Life Technologies, Inc.) in 6 ml of Opti-MEM (Life Technologies, Inc.) were added. In cotransfection experiments with two different plasmids, 6 g of each plasmid were added. The total amount of DNA was kept constant by supplementing with DNA from a vector encoding ␤-galactosidase. Twelve h after transfection, COS-7 cell transfectants were labeled with [ 32 P]orthophosphate (0.4 mCi/ml for 4 h) in phosphate-free Eagle's minimum essential medium. Cells were lysed on ice in 1 ml of 50 mM Hepes buffer, pH 7.4, containing 1% Triton X-100, 0.5% deoxycholate, 0.05% SDS, 150 mM NaCl, 5 mM MgCl 2 , 1 mM EGTA, 1 mg/ml of bovine serum albumin, 10 mM benzamidine, leupeptin-aprotinin-soybean trypsin inhibitor (10 g/ml), and 1 mM phenylmethylsulfonylfluoride. Nuclei and cellular debris were sedimented, and NaCl was added to lysates at a final concentration of 500 mM. After preclearing for 30 min with 8 g of protein A-Sepharose, samples were incubated with 4 g of rabbit polyclonal anti-Rho A (Santa Cruz Biotechnology) for 60 min at 4°C. Immunocomplexes were collected with 15 g of protein A-Sepharose for 90 min. The beads were washed eight times in 50 mM Hepes buffer, pH 7.4, 500 mM NaCl, 0.1% Triton X-100, and 0.005% SDS. Nucleotides were eluted in 5 mM EDTA, 2 mM dithiothreitol, 0.2% SDS, 0.5 mM GTP, and 0.5 mM GDP for 20 min at 68°C and separated by thin-layer chromatography on polyethyleneiminecellulose plates (Merck) run in 1 M KH 2 PO 4 , pH 3.4. The positions of unlabeled GDP and GTP standards on the plates were visualized under 254-nm UV light. Quantitations of radiolabeled nucleotides were performed with phosphoimaging (Fuji BAS 1500).
Microinjection-For microinjection studies, quiescent, serumstarved Swiss 3T3 cells (approximately 10 3 cells/mm 2 ) plated on glass coverslips marked with squares to facilitate the localization of injected cells were used. The cDNAs of G␣ 12 (Q229L; G␣ 12 QL), G␣ 13 (Q226L; G␣ 13 QL), and G␣ q (R183C; G␣ q RC), carried by the cytomegalovirus promotor-containing vector pCis, G␣ 11 (Q209L; G␣ 11 QL) cloned in pZeo, and empty vector controls, were applied for microinjection. Plasmids were microinjected into the nucleus alone or with Texas red-coupled dextran (5 mg/ml, Molecular Probes) to visualize injected cells. Clostridium botulinum C3 toxin was co-microinjected with the cDNAs described above at a final concentration of 100 g/ml. After microinjection, the cells were returned to the incubator for a further 90 min until fixation. As indicated, cells were treated with tyrphostin A 25 (150 M), tyrphostin A 1 (150 M), or genistein (30 g/ml) for 60 min. Tyrphostin AG 1478 (1 M) or tyrphostin AG 1296 (10 M) were added 120 min before fixation. To study cytoskeletal effects of extracellular factors, cells were incubated with LPA (0.3 M), thrombin (40 ng/ml), EGF (10 ng/ml), or bombesin (10 nM) for 10 min. The phosphatase inhibitor orthovanadate (100 M) was added to serum-starved cells 25 min before fixation. Antibodies against G␣ subunits were diluted and microinjected into the cytosol of cells followed by an incubation period of 60 min. The dominant negative EGF receptor mutant EGFR-CD533 carried by the pRK5 vector was expressed in Swiss 3T3 cells by nuclear microinjection. About 100 cells/field were injected in each case using a manual injection system (Eppendorf). Needles were pulled from capillaries with a horizontal micropipette puller (Sutter).
Fluorescence Microscopy-Microinjected or growth factor-treated cells were fixed in 4% paraformaldehyde for 20 min and permeabilized in 0.2% Triton X-100 for 5 min. For localization of actin filaments, cells were stained with 0.5 g/ml fluorescein isothiocyanate (FITC)-phalloidin (Sigma) for 40 min. Vinculin was detected after blocking with phosphate-buffered saline supplemented with 5% fetal bovine serum for 30 min, followed by incubation with a monoclonal anti-vinculin antibody (VIN-11-5; Sigma) for 60 min. Subsequently, cells were labeled with a FITC-conjugated goat anti-mouse antibody (Sigma) for 45 min. Antibody incubations were performed at room temperature. The coverslips were mounted on glass slides and examined on an inverted microscope (Zeiss Axiovert 100).
RESULTS
To characterize the G-protein coupling pattern of the LPA receptor in Swiss 3T3 fibroblasts, we first determined the expression of different PTX-insensitive G␣ subunits in these cells by performing immunoblot experiments with subtype-specific antibodies. Immunoblotting of membrane proteins with an antibody specific for G␣ q/11 (AS 369) identified the expression of the corresponding 42-kDa proteins (Fig. 1, lane 1) . Antisera raised against a C-terminal peptide of G␣ 12 (AS 232, AS 233) recognized a protein with an apparent molecular mass of 43 kDa ( Fig. 1, lanes 2 and 3) . In addition, these antisera crossreacted with several unknown proteins of higher and lower molecular masses that had not been detected in rodent and nonrodent brain membranes (17) . To assure the specificity of AS 232 and AS 233, which have been extensively characterized (17, 18) , we performed peptide competition experiments. Upon preincubation with the peptide used for their generation, the detection of G␣ 12 was abolished (data not shown). Immunoblotting of membranes with an antiserum specific for G␣ 13 (AS 343) recognized a protein of approximately 43 kDa (Fig. 1, lane 4) . These experiments indicate the expression of both G␣ 12 and G␣ 13 in Swiss 3T3 cell membranes.
In previous studies, interactions of the LPA receptor with G-proteins of the G i and G q subfamilies were postulated mainly from experiments showing the existence of PTX-sensitive as well as PTX-insensitive cellular effects of LPA (9) . To directly show the LPA-mediated activation of G-proteins, membranes of subconfluent Swiss 3T3 cells were photolabeled with [␣- 32 anti-␣ i (AS 266) antisera and visualized by autoradiography. Fig. 2 shows that stimulation of membranes with 10 M LPA induced an incorporation of [␣-
32 P]GTP azidoanilide into G␣ subunits of G q/11 , G 12 , G 13 , and G i proteins. For studying [␣- 32 P]GTP azidoanilide incorporation into G␣ 12 and G␣ 13 , the experiments were performed with prolonged incubation times of 30 min, whereas an agonist-induced activation of G␣ i was only observed with short incubation times, reflecting the substantial basal guanine nucleotide turnover of G i proteins. No increased incorporation of [␣-
32 P]GTP azidoanilide into G␣ 12 or G␣ 13 was found using lower concentrations of LPA (e.g. 1 M).
Expression of constitutively active mutants of G 12 subfamily members has been reported to induce a Rho-dependent formation of actin stress fibers in Swiss 3T3 cells (13) . To further characterize the functional role of G 12 and G 13 in LPA-induced and Rho-mediated regulation of the actin cytoskeleton, we first expressed constitutively active mutants of G␣ 12 (G␣ 12 Q229L; G␣ 12 QL) and G␣ 13 (G␣ 13 Q226L; G␣ 13 QL) in Swiss 3T3 fibroblasts by microinjecting expression plasmids into quiescent cells. Both G␣ subunits stimulated the formation of actin stress fibers, whereas GTPase-deficient forms of G␣ q (G␣ q R183C; G␣ q RC) and G␣ 11 (G␣ 11 Q209L; G␣ 11 QL) were unable to induce stress fiber formation (Fig. 3) . The expression of G␣ 12 QL and G␣ 13 QL was also accompanied by the formation of vinculin-containing spots with a characteristically elongated, arrowhead shape typical of Rho-induced assembly of focal adhesions (22) that were not observed upon microinjection of plasmids encoding G␣ q RC and G␣ 11 QL (Fig. 3) . The dependence of G␣ 12 QL-and G␣ 13 QL-mediated cytoskeletal effects on stimulation of Rho activity could be demonstrated employing purified recombinant C3 exoenzyme from C. botulinum (13) . C3 exoenzyme has been shown to inhibit the isoforms of Rho but no other members of the Rho family (21, 22) . Co-microinjection of C3 exoenzyme (100 g/ml) abolished the actin stress fiber formation induced by G␣ 12 QL and G␣ 13 QL (Fig. 4) . Likewise, focal adhesion assembly caused by both activated G␣ subunits was inhibited by C3 exoenzyme (data not shown). These results confirm that G 12 and G 13 are able to trigger Rho-dependent effects in Swiss 3T3 cells, whereas cytoskeletal remodeling typical of an activation of Cdc42 or Rac, i.e. formation of filopodia or membrane ruffles (23, 24) , was not observed. Interestingly, the phosphotyrosine phosphatase inhibitor orthovanadate (100 M), which has previously been shown to stimulate Rho in Swiss 3T3 fibroblasts (11) , also induced a selective formation of actin stress fibers without membrane ruffling or formation of filopodia (not shown). To test G 12 subfamily-induced Rho activation biochemically, we transiently overexpressed G␣ 12 QL and G␣ 13 QL in COS-7 cells and analyzed the incorporation of radioactive nucleotides in Rho A. Expression of activated G␣ 12 and G␣ 13 , but not of the ␤-galactosidase control, caused an accumulation of Rho-bound radioactive GTP. The ratio of bound GTP to total nucleotides bound to Rho [(GTP/ GTP ϩ GDP) ϫ 100] was 22 Ϯ 0.57% for the lacZ control, 28.75 Ϯ 0.92% for G␣ 12 QL, and 35.7 Ϯ 4.1% for G␣ 13 QL (Fig.  5 ). These data demonstrate that expression of G␣ 12 QL and G␣ 13 QL leads to an activation of Rho.
To characterize the function of individual G 12 subfamily members for LPA-induced activation of Rho in intact cells, we microinjected antibodies directed against the carboxyl termini of G␣ 12 and G␣ 13 . Actin stress fiber formation caused by LPA at a concentration of 0.3 M was suppressed by application of G␣ 13 -specific antiserum AS 343 (dilution of 1:50), whereas microinjection of the corresponding preimmune serum failed to influence LPA-induced cytoskeletal effects. Inhibition of LPAinduced stress fiber formation was also obtained using other G␣ 13 -specific antisera, i.e. AS 342 and AS 272 (not shown). Surprisingly, the G␣ 12 -specific antisera (AS 232, AS 233) did not inhibit the LPA-induced actin polymerization using dilutions of 1:1 to 1:50 (Fig. 6) . The application of antibodies against G␣ q/11 (AS 369) showed no effects on cytoskeletal reorganisation caused by LPA. These results suggest that in intact Swiss 3T3 cells, LPA-induced Rho stimulation may be mediated by G 13 but not by G 12 .
Since the tyrosine kinase inhibitor tyrphostin A 25 has been shown to block stress fiber formation evoked by LPA, but not by 3 . Stimulation of actin stress fiber formation and focal adhesion assembly by constitutively active G␣ subunits. Expression plasmids (100 ng/l) containing the cDNAs of G␣ 12 (Q229L), G␣ 13 (Q226L), G␣ q (R183C) or G␣ 11 (Q209L), or the empty vector (control) were microinjected into the nucleus of serum-starved, subconfluent Swiss 3T3 fibroblasts. Cells were fixed after 90 min with paraformaldehyde and permeabilized with Triton X-100. Actin stress fibers were revealed using FITC-labeled phalloidin (left panels), and focal adhesions were localized with a mouse anti-vinculin antibody followed by a FITC-conjugated goat anti-mouse antibody (right panels). Shown are cells from one of four independent experiments. microinjected Rho protein, an involvement of a tyrosine kinase acting upstream of Rho in the pathway of LPA-induced Rho activation appears to be likely (11) . To further study the mechanism whereby G 13 mediates the LPA-induced activation of Rho, we investigated effects of tyrosine kinase inhibitors on cytoskeletal changes induced by different stimuli. As demonstrated in Fig. 7A , tyrphostin A 25 (150 M) completely inhibited stress fiber formation induced by LPA and G␣ 13 QL (100 ng/l of cDNA) but not the cytoskeletal effects of G␣ 12 QL (100 ng/l of cDNA), further confirming the notion that LPA signals via G 13 to Rho. Focal adhesion assembly caused by LPA or G␣ 13 QL was also blocked by incubation with tyrphostin A 25, whereas focal adhesions induced by G␣ 12 QL were not influenced by this tyrosine kinase inhibitor (Fig. 7B) . To exclude that these differences in tyrphostin sensitivity were results of different expression levels of G␣ 12 QL and G␣ 13 QL, we studied cytoskeletal effects caused by various concentrations of expression plasmids. Cytoskeletal effects of G␣ 13 QL induced by injection of up to 1 g/l of cDNA were abolished by tyrphostin A 25. However, G␣ 12 QL-induced submaximal stress fiber formation after microinjection of 10 ng/l of cDNA was tyrphostin A 25-insensitive. Unlike tyrphostin A 25, the tyrosine kinase inhibitor genistein (30 g/ml), which has previously been shown to act downstream of Rho (12) , blocked the formation of actin stress fibers induced by LPA, G␣ 13 QL, and G␣ 12 QL (Fig.  7A) . The biologically inactive tyrphostin A 1 (150 M) showed no effects on cytoskeletal changes caused by LPA or the activated G␣ subunits (data not shown). Using more specific inhibitors of tyrosine kinases, we found that 1 M EGF receptor- specific tyrosine kinase inhibitor tyrphostin AG 1478 (25) completely blocked both the LPA-and G␣ 13 QL-induced formation of actin stress fibers (Fig. 8) . Lower concentrations of tyrphostin AG 1478 (e.g. 250 or 500 nM) partially suppressed actin polymerization caused by G␣ 13 QL. Cytoskeletal effects caused by G␣ 12 QL were not influenced by this tyrphostin at concentrations of up to 20 M. Tyrphostin AG 1296 (10 M), a selective platelet-derived growth factor receptor tyrosine kinase inhibitor, failed to affect stress fiber formation induced by LPA and G␣ 13 QL or by G␣ 12 QL (Fig. 8) . Actin stress fiber formation caused by orthovanadate was also inhibited by tyrphostin A 25 and tyrphostin AG 1478 but not by tyrphostin AG 1296 (data not shown).
The inhibitory effects observed with tyrphostins suggested a participation of the EGF receptor in G␣ 13 QL-induced Rho activation. Therefore, we expressed an EGF receptor mutant lacking 533 C-terminal amino acids (EGFR-CD533) in Swiss 3T3 cells by microinjection. It has been shown that this mutant exerts a dominant negative function on EGF receptor signaling by formation of signaling-incompetent heterodimers with the wild type receptor (26) . Fig. 9 shows that expression of the truncated receptor markedly suppressed actin stress fiber formation caused by LPA or by G␣ 13 QL. In agreement with the tyrphostin data shown above, G␣ 12 QL-induced actin polymerization was not inhibited by expression of EGFR-CD533. Furthermore, expression of the dominant negative EGF receptor mutant also abolished the cytoskeletal effects caused by orthovanadate (Fig. 9 ). To assess a role for the EGF receptor in G␣ 13 -mediated Rho activation, we transiently coexpressed G␣ 13 QL and EGFR-CD533 in COS-7 cells and determined the activation state of Rho by analyzing Rho-bound nucleotides. Fig. 10 demonstrates that the G␣ 13 QL-induced Rho-GTP accumulation was attenuated by co-expression of the mutated EGF receptor. The ratio of bound GTP to total nucleotides bound to Rho [(GTP/GTP ϩ GDP) ϫ 100] was 17.8 Ϯ 1.9% for the lacZ control, 25.8 Ϯ 0.2% for the coexpression of G␣ 13 QL with lacZ, and 22.5 Ϯ 0.1% for the coexpression of G␣ 13 QL with EGFR-CD533. This demonstrates that the dominant negative EGF receptor (EGFR-CD533) was able to inhibit G␣ 13 -induced activation of Rho. The expression of EGFR-CD533 with lacZ did not affect basal Rho-GTP levels compared with lacZ (not shown). These data clearly suggest the EGF receptor as a critical component in the pathway leading from G␣ 13 to Rho activation.
DISCUSSION
The phospholipid LPA has been characterized as a multifunctional messenger acting on adenylyl cyclases, phospholipases, mitogen-activated protein kinases, and the actin cytoskeleton via different pathways (9) . Previous studies demonstrated the existence of high affinity, guanine nucleotide-sensitive binding sites for LPA in membranes prepared from Swiss 3T3 cells and rat brains (27) . Recently, the cloning of LPA receptors from neuronal cells and Xenopus oocytes has been described (1, 2) . It has been suggested from experiments using PTX that some cellular effects of LPA are mediated by G-proteins belonging to G i or G q subfamilies (9) . The signaling cascade coupling the LPA receptor to an activation of Rho and subsequent remodeling of the actin cytoskeleton leading to stress fiber formation has, however, remained unclear. Results from previous studies indicated that LPA-induced Rho signaling is PTX-insensitive and that constitutively activated G␣ q subunits are not able to stimulate Rho, excluding G i and G q proteins from this pathway (9, 13) . On the other hand, expression of constitutively active mutants of G␣ 12 and G␣ 13 has been shown to trigger Rho-mediated stress fiber formation in Swiss 3T3 cells (13) . Therefore, we studied the involvement of G 12 subfamily proteins in the pathway from LPA receptor to stimulation of Rho/stress fiber formation. Activated G 12 and G 13 induced Rho-mediated stress fiber formation (see Fig. 3 ; Ref. 13 ). Furthermore, we were able to demonstrate activation of Rho by constitutively active mutants of G␣ 12 and G␣ 13 (see Fig.  5 ). In photolabeling experiments, both members of the G 12 subfamily appeared to interact with the LPA receptor; however, in intact cells, only G 13 , but not G 12 , mediated signaling from LPA receptor to Rho. This was suggested by discriminating effects of microinjected subtype-specific antibodies, by differences in tyrphostin sensitivity, and by the different requirement of EGF receptor function in LPA and G␣ 13 QL-versus G␣ 12 QL-induced Rho activation (see below). These data led us to identify G 13 as a mediator from LPA receptors to Rho. A likely explanation for the observed discrepancy between the photoaffinity assay and microinjection/Rho activation studies is that photolabeling studies had to be performed employing a high concentration of LPA (10 M), whereas a significantly lower concentration of 0.3 M LPA was sufficient to induce maximum Rho activation in live Swiss 3T3 cells. Moreover, our data suggest that selectivity in receptor signaling is often found to be higher in intact complex systems than in in vitro assays. Similar conclusions may be deducible from the specificity of G␤␥ dimers in signaling pathways, since studies with antisense oligonucleotides performed in intact cells revealed a higher selectivity than biochemical assays using purified components (28 -31) . The identification of G 13 as signal transducer from LPA receptor to Rho may suggest that other agonists of G-protein-coupled receptors that induce effects on the actin cytoskeleton may also act via G 13 and/or G 12 .
Previously, Nobes et al. (11) have indicated the existence of a protein-tyrosine kinase acting in the LPA pathway upstream of Rho. One major finding of the present study is that LPA-as well as G␣ 13 QL-induced effects on the actin cytoskeleton can be blocked with tyrphostins, suggesting that a tyrosine kinase activity is required for the signaling from G 13 to Rho. Although an inhibition of GTPase activity of transducin by tyrphostin A 25 has been reported (32), it appears unlikely that the suppression of G␣ 13 QL-induced Rho activation by this inhibitor might be a result of nonspecific interactions between tyrphostin A 25 and the G-protein, since GTPase-deficient mutants of G␣ sub- units were used. Furthermore, also the specific EGF receptor inhibitor tyrphostin AG 1478 blocked the effects. The implication of EGF receptor kinase activity in the LPA/G␣ 13 QL-induced, Rho-dependent stress fiber formation was substantiated by the expression of a dominant negative EGF receptor mutant in Swiss 3T3 cells. In addition, G␣ 13 -induced Rho-GTP accumulation was at least partially reversed after overexpression of the truncated EGF receptor mutant. Recently, several G-protein-coupled receptors have been reported to induce a ligandindependent activation of the EGF or platelet-derived growth factor receptor with subsequent activation of mitogen-activated protein kinase cascades, and an involvement of G i -type Gproteins in this transactivation pathway has been suggested (33) (34) (35) . However, neither active G␣ i nor G␤␥ dimers lead to a reorganization of the actin cytoskeleton (13) . Our data suggest an involvement of the receptor tyrosine kinase EGF receptor in the pathway of G 13 -mediated actin stress fiber formation. The presumably complex mechanism whereby the EGF receptor influences signaling mediated by activated G␣ 13 has yet to be resolved. Using serum-starved Swiss 3T3 cells stimulated with LPA, we found neither a coimmunoprecipitation of G␣ 13 with the EGF receptor or with a nonreceptor tyrosine kinase of the Src family nor a tyrosine phosphorylation of G␣ 13 , arguing against the possibility of a direct interaction between G␣ 13 and a tyrosine kinase. 2 On the other hand, strong similarities were observed between cytoskeletal events induced by LPA or G␣ 13 QL and those caused by orthovanadate, pointing to the possibility that activated G␣ 13 may cause a ligand-independent stimulation of the EGF receptor by interacting with a phosphotyrosine phosphatase. The identification of a putative receptor tyrosine kinase/phosphatase cycle controlling the communication between activated G 13 and Rho is under current investigation. Taken together, our data indicate that G 13 couples the LPA receptor to Rho activation in Swiss 3T3 cells. In addition, we provide evidence for an involvement of the EGF receptor in the pathway leading from G 13 to Rho activation/stress fiber formation.
